SAIA heads into the week before its July 31 earnings with a notable alignment: analysts raising targets in unison, short sellers trimming positions, and the stock trading fractionally above the newly lifted Street consensus.
The analyst story is the clearest signal this week. JP Morgan lifted its price target to $490 on June 8, maintaining Overweight — the second time the firm has raised its target in five weeks, having already bumped it from $402 to $465 after the Q1 print. Wells Fargo moved to $490 on June 5, BMO to $470 on June 4, and Susquehanna to $465 on June 2. Every move this week was a raise, none were upgrades — the Street broadly sees fair value approaching but isn't pushing for a re-rating. The mean target now sits at $452.55, slightly below the current price of $479.30, which means SAIA has effectively traded through consensus. Citi's $516 target from early May is the bullish outlier; the cluster of neutrals and holds around $465–$490 sets the practical ceiling the Street is willing to defend. PE stands near 37.9x, up roughly 1.4 points over the past month, and EV/EBITDA at 18.2x — elevated multiples that explain why several of the raising analysts kept cautious ratings even as they lifted numbers.
Short positioning has been quietly unwinding, which softens any squeeze narrative. Bears trimmed almost 7% of their position in a single session on June 9, pulling short interest to roughly 4.3% of the free float — down about 5% on the week and off its recent highs from mid-May, when it briefly touched the equivalent of ~1.27 million shares. Borrow conditions offer no signal of stress: cost to borrow is a negligible 0.43%, and availability is extraordinarily loose at 3,380% — meaning there are more than 33 shares available to borrow for every one currently lent out. That reading is down from around 4,400% at the start of the week but still far above the 52-week trough of 704%, so there is no meaningful constraint on new shorts. The borrow market is telling a story of indifference rather than conviction in either direction.
Options positioning has eased from its more defensive posture of a month ago. The put/call ratio is running at 1.14, almost a full standard deviation below its 20-day average of 1.23 — a notable shift given that through late May the PCR was persistently above 1.35. That earlier cluster of put-buying coincided with the stock's softness into mid-May; the unwinding now tracks the 6.6% recovery over the past month to $479.30. The 52-week PCR range runs from 0.77 to 2.74, so neither extreme is in play — positioning looks broadly neutral rather than charged.
Institutional ownership reinforces the picture of genuine long conviction. T. Rowe Price holds 10.4% of shares and added 417,000 shares in the most recent filing period. AllianceBernstein, at 9.4%, added 209,000 shares. Both are active managers, not passive holders — the combined ~20% stake in two engaged institutions provides a real floor. First Trust added 163,000 shares over the same window. Insider activity tells a more cautious story: the CEO sold $1.86 million of stock in February, the CFO and Chief Customer Officer also sold that same day. The most recent insider trade — a small HR Director sale on May 20 — is noise, and the 90-day net is modestly positive at roughly $212,000, driven almost entirely by minor activity rather than a directional statement.
Earnings history adds context for the July 31 print. The Q1 release on May 1 produced a sharp negative one-day reaction of -9.7%, even as the five-day window recovered to essentially flat. The prior event delivered a +4.6% one-day move that extended to +6.4% over the week. That asymmetry — a big down day followed by a recovery, or a smaller up day that sustains — suggests the market tends to overshoot the initial reaction. The stock is trading through consensus and carrying a 37.9x PE into a print that arrives in seven weeks, making the July 31 release the next meaningful test of whether the raised targets reflect achievable numbers or optimistic extrapolation of the Q1 momentum.
See the live data behind this article on ORTEX.
Open SAIA on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
